Stock MDXG MIMEDX GROUP, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus MiMedx Group, Inc.

Equities

MDXG

US6024961012

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-04-26 EDT 		5-day change 1st Jan Change
6.27 USD +0.40% Intraday chart for MiMedx Group, Inc. -0.32% -28.51%
03-27 MiMedx Group Says FDA Affirms Axiofill Falls Short of Regulatory Standards for Tissue-Based Products MT
03-27 MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit DJ

Evolution of the average Target Price on MiMedx Group, Inc.

Price target over the last 5 years

History of analyst recommendation changes

51b.4jYV30HrfAGo3k1Ab2kEHE9OAF4-sfwvOnbwqGf-RDs.rl1Z6zvZBUXikSZ0Hgp-TBU_SRV058xmSjCFmx2MKkvWQGyUJKgJaMOxPg~c10d5003550c59d75cbe34629dc94a37

Analyst Recommendations on MiMedx Group, Inc.

Lake Street Starts MiMedx Group With Buy Rating, $12 Price Target MT
Mizuho Securities Raises Price Target on MiMedx to $14 From $13, Maintains Buy Rating MT
Mizuho Securities Adjusts MiMedx Price Target to $12 From $14, Maintains Buy Rating MT
Mizuho Adjusts Price Target on MiMedx Group to $12 From $10, Maintains Buy Rating MT
HC Wainwright Adjusts Price Target on MiMedx Group to $11 From $8, Maintains Buy Rating MT
HC Wainwright Adjusts Price Target on Medx Group to $8 From $9.50, Keeps Buy Rating MT
HC Wainwright Adjusts Price Target on MiMedx Group to $9.50 From $8, Maintains Buy Rating MT
Mizuho Securities Starts MiMedx Group at Buy With $7 Price Target MT
HC Wainwright Adjusts MiMedx Group's Price Target to $8 from $8.50, Reiterates Buy Rating MT
MIMEDX : HC Wainwright Adjusts Price Target for MiMedx Group to $8.50 From $20, Maintains Buy Rating MT
MIMEDX : Northland Capital Reinstates MiMedx Group at Outperform with $23 Price Target MT
MIMEDX : HC Wainwright Starts MiMedx Group at Buy With $20 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
6.27 USD
Average target price
12.44 USD
Spread / Average Target
+98.35%
High Price Target
14 USD
Spread / Highest target
+123.29%
Low Price Target
10.62 USD
Spread / Lowest Target
+69.38%

Consensus detail

Consensus revision (last 18 months)

Analysts covering MiMedx Group, Inc.

Lake Street
Mizuho Securities
HC Wainwright
Northland Securities

Ratings for MiMedx Group, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. MDXG Stock
  4. Consensus MiMedx Group, Inc.